According to the report, the global plantar fasciitis treatment market was valued at ~ US$ 695 Mn in 2018, and is projected to expand at a CAGR of 4.3% from 2019 to 2027.
Rise in the patient population and surge in the adoption of technologically-advanced products are the major factors anticipated to drive the global plantar fasciitis treatment market from 2019 to 2027.Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=47658Increase in Burden of Patient Population to Drive Plantar Fasciitis Treatment MarketPlantar fasciitis is one of the most common foot pain conditions.
Plantar fasciitis is primarily caused due to repetitive strain on the ankle, leading to progressive wear and tear and degeneration of plantar fascia, a thick connective tissue covering the lower side of the foot.The obese and geriatric populations are more prone to plantar fasciitis.
It leads to sharp pain and other complications, in which, plantar fascia, a tissue connecting the heel and the toe bones becomes less flexible and more constrained.Rise in the number of individuals living sedentary lifestyles coupled with changes in eating habits leads to an increase in obesity, which puts pressure on the joints and ankles, and can result in plantar fasciitis.Increase in the percentage of geriatric and obese populations is likely to propel the number of patients suffering from plantar fasciitis.Moreover, prolonged standing, weight bearing, ill-fitted shoes, incorrect walking posture, and sudden rise in sports activities can trigger micro-tears in the plantar fascia, and lead to plantar fasciitis.This multi-factorial etiology of the disease is anticipated to drive the global plantar fasciitis treatment market during the forecast period.Request COVID Analysis on Plantar Fasciitis Treatment Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=47658Orthotics Treatment Type to Gain Market Share and offer Lucrative OpportunitiesThe report offers detailed segmentation of the global plantar fasciitis treatment market based on type, end user, and region.
Increase in the penetration of leading players in the region is expected to boost the plantar fasciitis treatment market in the region during the forecast period.The plantar fasciitis treatment market in Asia Pacific is primarily driven by the surge in investments in healthcare infrastructure, rise in disposable income of people, economic growth, large population base with chronic diseases & other foot pain conditions, and expansion in the distribution networks of leading players in the region to establish themselves in lucrative plantar fasciitis treatmentBuy Continuous Plantar Fasciitis Treatment Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=47658=SDr.
These include Hanger, Inc., Bayer Group (Dr. Scholl's), A. Algeo Limited, Bauerfeind AG, Superfeet Worldwide, Inc., Ottobock SE & Co. KGaA (Ottobock Holding), Pfizer, Inc., Sanofi, and GlaxoSmithKline plc.Hanger, Inc. is a U.S.-based manufacturer and distributor of orthotic and prosthetic devices, and provides therapeutic solutions to patients and businesses in acute, post-acute, and clinic settings.
